H I Scher

Effective antigen cross-presentation by prostate cancer patients' dendritic cells: implications for prostate cancer immunotherapy

R. Darnell, H. Scher, M. Albert, 2004, Prostate Cancer and Prostatic Diseases.

Relative contribution of normal and neoplastic cells determines telomerase activity and telomere length in primary cancers of the prostate, colon, and sarcoma.

V. Reuter, H. Scher, J. Guillem, 1997, Clinical cancer research : an official journal of the American Association for Cancer Research.